The NIH Director
The Washington Post Editorial Board supports the Accelerating Medicines Partnership’s goal to find new biomarkers for Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus. The Washington Post. February 8, 2014. Read More
In the New York Times, Dr. Collins lauds the Accelerating Medicines Partnership as a unique collaboration which will work towards expediting the identification of new drug targets for three major disease areas. New York Times. February 4, 2014. Read More
In a commentary for Nature, Drs. Collins and Tabak discuss the NIH’s initiatives to improve reproducibility, particularly in preclinical research. Collins, Francis S., and Tabak, Lawrence A. “NIH plans to enhance reproducibility.” Nature 505, 612-613 (27 January 2014). Read More
In The Atlantic, Dr. Collins reflects on the funding challenges from 2013 sequester cuts and how a continued lack of investment in biomedical research may curb opportunities for U.S. leadership in the field. The Atlantic. December 18, 2013. Read More
In The Wall Street Journal’s 12 Months of Reading, Dr. Collins recommends that young scientists read Mario Livio's "Brilliant Blunders," which makes a point that scientific blunders can in fact be opportunities rather than setbacks. The Wall Street Journal. December 13, 2013. Read More
Dr. Collins and FDA Commissioner Dr. Margaret Hamburg author an article in the Perspective section of the New England Journal of Medicine, about FDA’s landmark decision to grant marketing authorization for a next-generation sequencer. The article explores how bringing this technology into use for clinical care will transform patient engagement, increase the use of genetic information in health care, and expand research. Collins, Francis S. M.D., Ph.D., and Hamburg, Margaret A., M.D. New England Journal of Medicine. November 19, 2013. Read More
Dr. Collins speaks to Wall Street Journal’s Joseph Rago about the biomedical opportunities at risk from NIH budget cuts. Wall Street Journal. November 8, 2013. Read More
Dr. Collins co-authors an article in SciTM explaining the benefits of the PCORI network and how it will help develop clinical research networks with new synergies and efficiencies that partners patients with researchers. Science Translational Medicine Rapid Publication, Vol. 5, Issue 182, p. 182fs13, April 23 2013.
NIH Director Dr. Francis Collins and his research collaborators share what they’ve learned about how basic cell biology can be translated to the clinic. Journal of Cell Biology, Vol. 199, October 1, 2012.
NIH Director Dr. Francis Collins and NIDDK Director Dr. Griffin Rodgers address the importance of research in developing practical and effective strategies to reverse the Nation's obesity epidemic. JAMA. 2012; 308(11):1095-1096. Read More
Mobile devices have the potential to become powerful medical tools A commentary from NIH Director Francis Collins on mobile health technology and how it can benefit both patients and researchers. Scientific American, July 2012 Online Issue, June 24, 2012. Read More
NIH Director Dr. Francis Collins and Dr. Mahendra S. Rao, director for the new NIH Intramural Center for Regenerative Medicine, discuss the role the new center will play for the future of stem cell research. Stem Cells Translational Medicine, Vol. 1, January 2012. Read More
NIH Director Dr. Francis Collins and three fellow NIH experts discuss the effects of household stoves. Read their commentary on one of the leading causes of indoor air pollution that affects nearly half the world's population. Science, Vol. 334, October 14, 2011. Read More
Dr. Francis Collins discusses the potential benefit of clinical trials to medical research aimed at improving human health. NIH Medline Plus the Magazine, Summer 2011.
In Science Translational Medicine, Director Dr. Francis S. Collins sets forth NIH’s vision for advancing translational sciences. Science Translational Medicine, July 6, 2011. Read More
Dr. Francis Collins discusses the need to apply scientific innovation to global health research. Huffington Post, June 15, 2011
The study of the more than 6,000 known rare diseases not only can improve understanding of those disorders, but may also shed new light on hundreds of more common diseases. Dr. Francis Collins discusses the increasing promise of genetics research for the diagnosis, treatment, and prevention of both rare and common diseases. NIH Medline Plus the Magazine, Spring 2011. Read More
Dr. Francis Collins discusses a variety of topics including whole genome sequencing, NIH’s efforts in global health research, and the Genetic Information Nondiscrimination Act (GINA). Yale Journal of Medicine and Law, Vol. VII, Issue 2, Spring, 2011 Read More
The use of mobile technologies for health research and healthcare delivery is rapidly expanding. Dr. Francis Collins discusses the impact of these cell phone technologies on global health and how NIH is trying to bring medical information to the public. NIH Medline Plus the Magazine, Winter 2011. Read More
NIH Director Francis Collins explains why the NIH is launching
a bid to help some doctoral students dramatically reduce the
time required to start an independent career.
Nature, Vol.467, 7 October 2010. Read More
By NIH Director Francis S. Collins, M.D., Ph.D., and AHRQ Director Carolyn Clancy, M.D, Sci Transl Med, June 23, 2010.
Using Science to Improve the Nation's Health System: NIH's Commitment to Comparative Effectiveness Research
Read the commentary in the Journal of the American Medical Association on comparative effectiveness research (CER) and NIH’s leadership role by NIH Director Francis Collins and Dr. Michael Lauer. JAMA. 2010;303(21):2182-2183. Read More
Information about the Notice of Proposed Rule Making appears in the Journal of the American Medical Association (JAMA) commentary by NIH Director Francis Collins and Dr. Sally Rockey. JAMA. 2010;303(23). Read More
The mission of the National Institutes of Health (NIH) is science in pursuit
of fundamental knowledge about the nature and behavior of living
systems and the application of that knowledge to extend healthy
life and to reduce illness and disability.